Bone marrow (stem cell) transplant is a potentially life-saving treatment for several types of cancer as well as other disorders that disrupt the blood cell production, such as sickle cell disease. At NewYork-Presbyterian, we provide bone marrow transplants at medical centers affiliated with two Ivy League medical colleges — NewYork-Presbyterian/Weill Cornell Medical Center, NewYork-Presbyterian/Columbia University Irving Medical Center, as well as NewYork-Presbyterian Morgan Stanley Children's Hospital.
Our teams are world-renowned not only for providing these therapies, but for conducting pioneering research that has enhanced their effectiveness and reduced related complications. We strive to extend access to bone marrow transplants to the diverse population of New York City and the Tristate area and are committed to reducing health disparities by addressing barriers to care.
The length and intensity of bone marrow transplant and its side effects require a multidisciplinary team of experts who collaborate to provide patients with customized care before, during, and after treatment. You can find that level of expertise and comprehensive care at NewYork-Presbyterian.